Anne Simonsen
Professor Anne Simonsen leads the Autophagy research group at the Inst for Cancer Research, Oslo University Hospital, and is the co-director of the Centre of Excellence CanCell (Centre for Cancer Cell Reprogramming) at the University of Oslo, Norway. She received her PhD in 1996 and during her postdoc, she identified the FYVE domain as a specific PtdIns(3)P binding domain and EEA1 as a PtdIns(3)P and RAB5 effector protein important for endosome fusion. She started her laboratory at the University of Oslo in 2009, where she became a full professor in 2011. The main objective of the Simonsen laboratory is to unravel the molecular mechanisms involved in selective types of autophagy and their role in normal health and disease. Specific focus areas include characterization of the role of hypoxia-induced mitophagy in cancer development and protein aggregate clearance in neurodegenerative disease. Her lab also has a continued interest in ALFY and other BEACH-domain-containing proteins. They use mammalian cell lines, various in vitro approaches, and zebrafish for their discoveries. She has authored more than 120 papers and has an H-index of 66. She is a member of the Norwegian Academy of Sciences and an elected member of EMBO.
Abstracts this author is presenting: